Chief Officer for Research Integrity, Quality, and Excellence
Linda Coleman is the Chief Officer for Research Integrity, Quality, and Excellence at CTAC. Ms. Coleman is an internationally renowned leader in clinical research quality and human subjects protection and brings a wealth of expertise to the role. She is currently the Associate Vice Provost, Research Policy & Integrity at Stanford University, where she oversees areas including research security, conflict of interest, data governance and privacy, and the responsible and ethical conduct of research. Before joining Stanford, she was the Director of the Human Research Protection Program at Yale University. Prior to Yale, Linda held progressive roles, including Vice President of Legal & Regulatory Affairs and Director of Regulatory Affairs & General Counsel, at Quorum Review (now part of Advarra), an independent IRB and consulting organization serving institutional, independent, and international research sites. Earlier in her career, she worked as an Attorney at Bennett, Bigelow & Leedom, focusing on health law, Medicare and Medicaid reimbursement, litigation, behavioral health, and employment law.
Ms. Coleman is actively engaged in in the research community and has contributed her expertise to various advisory and governance roles. She was a member of the Secretary’s Advisory Committee on Human Research Protection (SACHRP) from 2019 to 2022, served as the Co-Chair on SACHRP’s Subcommittee (SAS) from 2023-2024, and beginning in mid-2024 now serves as the Chair of the SACRP Subcommittee. Additionally, she serves on Boards such as the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Public Responsibility in Medicine & Research (PRIM&R), and the Northwest Association for Biomedical Research (NWABR). She is also a frequent speaker on topics such as good clinical practice, decentralized clinical trials, data privacy & protection issues, process improvement, research quality & compliance, responsible and ethical conduct of research, global research issues, research capacity building, bioethics, global research issues, and improving access to healthcare and research participation.
Main Menu
The Learning Phase includes:
Connecting Clinical Trial Sponsors: Bringing sponsors and local EQBMED-selected sites together to work as partners.
Sharing Key Learnings: Sharing important lessons learned from these partnerships.
Building Robust Infrastructure: Creating a strong support system that continues to support the growth and aspirations of local sites.
